HM
TENX icon

HealthCor Management’s Tenax Therapeutics TENX Stock Holding History

HealthCor Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-47
Closed -$8.32M – 67
2014
Q1 		$8.32M Buy
+47
New +$9.3M 0.5% 39

Other funds holding TENX

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthCor Management's TENX Position: Q2 2014 in Review

HealthCor Management sold out of Tenax Therapeutics (TENX) in Q2 2014, closing a stake of 47 shares — an estimated $8.32M sold.

HealthCor Management first reported a position in TENX in Q1 2014 and held it in 1 quarter. The position peaked at $8.32M in Q1 2014. 18 funds tracked by Wall St. Rank hold TENX as of Q2 2014.

  • HealthCor Management reported no remaining Tenax Therapeutics position as of Q2 2014 after selling out during the quarter.
  • HealthCor Management sold 47 Tenax Therapeutics shares in Q2 2014, an estimated $8.32M.
  • HealthCor Management first reported a position in Tenax Therapeutics in Q1 2014 and held it in 1 quarter.
  • HealthCor Management's Tenax Therapeutics position peaked at $8.32M in Q1 2014.
  • 18 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2014.

Based on HealthCor Management's 13F filing for Q2 2014, filed 14 Aug 2014.